CANF Total Costs & Expenses

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Total Costs & Expenses

CANF Total Costs & Expenses

Latest reported$10.14Mperiod endingJun 30, 2026

CANF Total Costs & Expenses ($4.51M → $10.14M)

Annual Total Costs & Expenses

Share image ↗High-resolution chart · PNG

CANF total costs & expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Total Costs & Expenses — Annual fiscal periods (USD)

Period ending	Total Costs & Expenses (USD)
Dec 31, 2025	10,437,146
Dec 31, 2024	8,804,000
Dec 31, 2023	8,938,000
Dec 31, 2022	10,906,000
Dec 31, 2021	13,695,000
Dec 31, 2020	14,902,000
Dec 31, 2019	14,039,000
Dec 31, 2018	9,234,000
Dec 31, 2017	8,220,451
Dec 31, 2016	8,803,358
Dec 31, 2015	6,579,722
Dec 31, 2014	7,132,382
Dec 31, 2013	8,991,241
Dec 31, 2012	6,004,379
Dec 31, 2011	5,267,997
Dec 31, 2010	4,509,031